|
|
|
Volumn 3, Issue 3, 2002, Pages 433-436
|
|
AGI-1067: AtheroGenics
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
CHOLESTEROL;
HYPOCHOLESTEROLEMIC AGENT;
PROBUCOL;
PROBUCOL SUCCINATE;
UNCLASSIFIED DRUG;
VASCULAR CELL ADHESION MOLECULE 1;
VASCULAR CELL ADHESION MOLECULE 1 CASCADE INHIBITOR;
WO 00170757;
WO 00179164;
WO 00198291;
ANGIOPLASTY;
ATHEROSCLEROSIS;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
EXPERIMENTAL MODEL;
HUMAN;
HYPERCHOLESTEROLEMIA;
LONG QT SYNDROME;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
RESTENOSIS;
REVIEW;
SIDE EFFECT;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ARTERIOSCLEROSIS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
GENE EXPRESSION REGULATION;
HUMANS;
STRUCTURE-ACTIVITY RELATIONSHIP;
VASCULAR CELL ADHESION MOLECULE-1;
|
|
EID: 0036229969
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (17)
|
